BioInItaly Newsletter

La vetrina del biotech italiano all’estero
  • 03 lug, 2015
    TES Pharma and école Polytechnique Fédérale de Lausanne (EPFL) Announce R&D Collaboration on Small Molecule Therapies for Metabolic Disorders and Age-Related Diseases

    MolMed winner of sixth edition of the Annual Most Innovative EU Biotech SME Award
  • 30 apr, 2015
    Amgen receives EU approval for a new indication of Vectibix (panitumumab)
    MolMed expands its pipeline by entering the CAR-T field having exercised the option right on San Raffaele Hospital CAR-CD44v6 project
    Aptuit LLC and Axxam SpA announce Strategic Alliance for Integrated Drug Discovery Services
    CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be Presented in Late-Breaking Session at ASCO
    Advancing competent professionals in  Medicines Development, a PHARMATRAIN – IFAPP – SSFA CONFERENCE
  • 30 mar, 2015
    The Italian Biotech Start-up founded by San Raffaele Hospital, Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner, raised a Euro 10 million ($11 million) Series A round with the support of Banca Esperia
    Developing selective epigenetic drugs for leukemia: the European Institute of Oncology enters into a drug discovery collaboration with the biotech Rasna Therapeutics
    Takis to present encouraging data on stromal cancer vaccine at the American Association for Cancer Research
    THERAMetrics Holding AG and Centurion Pharma are currently finalizing an agreement relevant to the development, registration and distribution of Aviptadil in Sarcoidosis in Turkey and the MENA Region
    MolMed enters into a strategic collaboration with GSK for development, manufacturing and technology transfer in gene therapy
    Nicox receives Orphan Drug Designation from FDA for naproxcinod in Duchenne Muscular Dystrophy
  • 06 mar, 2015
    Lofarma biotechnology to fight moulds-allergy with drops
    THERAMetrics: through Innovation and Technology
    Celgene: a positive decision for NHS reimbursement of ABRAXANE®
  • 30 gen, 2015
    The Merck Serono S.p.A. plant in Modugno-Bari opened  its doors to the Department of Pharmacy  and Pharmaceutical Sciences of the Bari University
    A biomarker for nonalcoholic steatohepatitis (NASH)  
    Newron initiates Phase II study of sNN0029 in patients with Amyotrophic Lateral Sclerosis and of sNN0031 in patients with Parkinson’s disease
  • 22 dic, 2014
    Collaboration agreement between Rare Partners and the Department of Life Sciences and Biotechnology of Ferrara University, Italy
    Takis' monoclonal antibodies suppress resistance mechanisms in melanoma
    HMP recommends Approval of XadagoTM (safinamide) to treat Parkinson´s disease in the EU
    Alzheimer’s Drug Discovery Foundation and Axxam continue their successful collaboration to develop novel therapeutics for Alzheimer’s disease
  • 25 nov, 2014
    Axxam SpA enters into research collaboration with F.Hoffmann ñ La Roche Ltd. for assay development and screening of selected drug targets.
    Lofarma announces the winners of the Prize "Giuseppe Centanni".
    Purolite Life Sciences introduces high-resolution agarose based chromatography resins for protein purification.
    Novartis drug SigniforÆ approved in EU, marking an advance for patients with inadequately controlled acromegaly.
  • 15 set, 2014
    Tetravil, a novel biopharmaceutical therapeutic agent for the therapy of rheumatoid arthritis
    Servier and CTI Biopharma announce exclusive license and collaboration agreement to develop and commercialize Pixuvri®
    Amgen submits Biologics License Application for investigational BiTE® immunotherapy Blinatumomab
    Amgen submits Marketing Authorization Application for Talimogene Laherparepvec to the European Medicines Agency
    EryDel Appoints René Goedkoop, MD, as Chief Medical Officer
    Nicox continues European ophthalmic expansion with acquisition of Doliage in France and of the Carragelose® anti-viral eye drop program
    Nicox launches Xailin Gel, an innovative "preservative-free in the eye" dry eye lubricant
  • 29 lug, 2014
    CTI BioPharma expands access to PIXUVRI® with approval in Israel and add-on reimbursement status in the Netherlands
    The map of Tuscany life sciences companies makes easier investing and attracting resources
    Newron establishes US operations
    Newron shares to be included in the SXI Life Sciences® and the SXI Bio+Medtech® indices
    Nicox focuses US operations on national launches of Sjö(TM) and RetnaGene(TM) and restructures RPS® licensing agreement
    Lofarma is going to open to new markets
    Pancreatic Cancer meeting in Ravello sponsored by BIOUNIVERSA  (August 31st  - September 1st)
  • 08 lug, 2014
    Leading cancer institutes from Milan enter into major alliance with Biovitas Capital to generate new molecular diagnostics
    Nicox to acquire Aciex Therapeutics, Inc.
    Lofarma develops recombinant probiotics to treat allergies
    Purolite and c-LEcta collaborate to market CalB immo Plus™ immobilized enzyme
    Chicago and Tuscan bio-parks set collaboration agreement
    The intriguing dynasty of Citrus
    Explora Biotech’s Ulysses technology will design NEXT immune-shielding peptides
  • 06 mag, 2014
    Axxam launches the ion channelFLASH technology based on light mediated activation of voltage-gated ion channels
    MolMed reports top line results of NGR-hTNF in the phase III trial in malignant pleural mesothelioma
    PIXUVRI® launched in UK for adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
    Newron raises CHF18.6m in private placement to existing and new institutional shareholders in Europe and the USA
  • 07 apr, 2014
    STPS: New Italian bioplastics come from microbial fermentation
    MolMed: TK submission for Conditional Approval validated by EMA
    Nicox launches AdenoPlus® and Xailin(TM) dry eye product range in Europe
    Newron: New results with NW-3509 demonstrate potential of unique mechanism to benefit poor responders to antipsychotics in patients with schizophrenia
    Safinamide Application for Authorization submitted to Swissmedic
    Lofarma Biotechnology arrives at Russian Federation